IDiyas

For the Inventor, By the Inventor

Morristown, NJ, United States of America

Nalpropion Pharmaceuticals LLC


USPTO Granted Patents = 14



Trademarks = 12

Forward Citations = 24

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Preston Klassen (7 out of 11 patents)

silverMedal Kristin Taylor (7 out of 15 patents)

bronzeMedal Gary Dennis Tollefson (5 out of 20 patents)

4.  Eckard Weber (4 out of 70 patents)

5.  Michael Alexander Cowley (2 out of 10 patents)

6.  Anthony A McKinney (2 out of 10 patents)

7.  Eduardo Dunayevich (2 out of 5 patents)

8.  Rick Soltero (1 out of 5 patents)

9.  Richard Soltero (1 out of 13 patents)

10.  Thea Elise Dunzo (2 patents)

11.  Shawn Flanagan (0 patent)

12.  Anthony A Mckinney (0 patent)

13.  Shawn Flanagan (0 patent)

14.  Gary (deceased) Tollefson (0 patent)

15.  Shawn Flanagan (0 patent)


14 patents:

1. 12048769 - Methods for administering weight loss medications (2024-07-30),
2. 11998542 - Compositions and methods for reducing major adverse cardiovascular events (2024-06-04),
3. 11324741 - Methods for treating visceral fat conditions (2022-05-10),
4. 11278544 - Compositions for affecting weight loss (2022-03-22),
5. 11139056 - Methods of treating overweight and obesity (2021-10-05),
6. 11033543 - Methods of providing weight loss therapy in patients with major depression (2021-06-15),
7. 10835527 - Compositions and methods for reducing major adverse cardiovascular events (2020-11-17),
8. 10828294 - Compositions and methods for weight loss in at risk patient populations (2020-11-10),
9. 10403170 - Methods of treating overweight and obesity (2019-09-03),
10. 10322121 - Methods of providing weight loss therapy in patients with major depression (2019-06-18),
11. 10307376 - Methods for administering weight loss medications (2019-06-04),
12. 10238647 - Compositions for affecting weight loss (2019-03-26),
13. 10231964 - Compositions and methods for weight loss in at risk patient populations (2019-03-19),
14. 10231962 - Compositions and methods for reducing major adverse cardiovascular events (2019-03-19),
Nalpropion Pharmaceuticals LLC is a leading biopharmaceutical company dedicated to the development and commercialization of innovative therapies for weight management. With a strong focus on research and development, Nalpropion aims to provide effective solutions for obesity and related health issues. Our experienced team and advanced facilities enable us to bring groundbreaking pharmaceutical products to market, improving patient outcomes and quality of life.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

14 Patents

#15 in Morristown, NJ

#839 in New Jersey

#21,598 in US

#40,882 in the World

...
Morristown, NJ, United States of America

Nalpropion Pharmaceuticals LLC

Forward Citations = 24

20 inventors:

goldMedal Preston Klassen (7 out of 11 patents)

silverMedal Kristin Taylor (7 out of 15 patents)

bronzeMedal Gary Dennis Tollefson (5 out of 20 patents)

4.  Eckard Weber (4 out of 70 patents)

5.  Michael Alexander Cowley (2 out of 10 patents)

Please report any incorrect information to support@idiyas.com
Loading…